ISRCTN ISRCTN89432944
DOI https://doi.org/10.1186/ISRCTN89432944
Secondary identifying numbers N/A
Submission date
09/11/2009
Registration date
17/11/2009
Last edited
27/01/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Estevao Lafuente
Scientific

Intensive Care Unit
Hospital Padre Americo
Guilhufe
Penafiel
4560-007
Portugal

Study information

Study designRandomised controlled parallel trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleEffects of fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomised, controlled clinical trial
Study acronymFOS
Study objectivesParenteral fish oil will reduce inflammation and improve clinical outcomes in septic patients in the intensive care unit (ICU).
Ethics approval(s)Comissão de Ética para a Saúde, Hospital Padre Américo, Penafiel, Portugal, approved on the 7th February 2007 (reg. no.: 1142; chair: Dr Braga da Cunha)
Health condition(s) or problem(s) studiedSystemic inflammatory response syndrome/sepsis
InterventionTotal parenteral nutrition including a lipid mixture providing a 50:50 mixture of coconut oil and soybean oil (Nutriflex Lipid Special) versus total parenteral nutrition (Nutriflex Special) including a lipid mixture providing a 50:40:10 mixture of coconut oil, soybean oil and fish oil (Lipoplus). Parenteral nutrition was administered continuously over 24 hours from soon after admission to the ICU until enteral feeding could be initiated, which was beyond day 6. Study samples were collected until day 6 and patient follow-up continued until they left hospital.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Parenteral fish oil
Primary outcome measure1. Plasma phospholipid fatty acid status at days 0, 1, 2 and 6
2. Plasma inflammatory cytokines at days 0, 1, 2 and 6
3. Inflammatory cytokine production by endotoxin stimulated whole blood at days 0, 1, 2 and 6
4. Length of ICU and hospital stay
Secondary outcome measures1. Respiratory function at days 0, 1, 2 and 6
2. Mortality up to day 28
Overall study start date01/03/2007
Completion date31/12/2007

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants25
Key inclusion criteria1. Systemic inflammatory response syndrome or sepsis
2. Predicted to need parenteral nutrition
3. Assigned to ICU
4. Over 18 years of age, either sex
Key exclusion criteria1. Able to be enterally fed
2. Under 18 years of age
Date of first enrolment01/03/2007
Date of final enrolment31/12/2007

Locations

Countries of recruitment

  • Portugal

Study participating centre

Intensive Care Unit
Penafiel
4560-007
Portugal

Sponsor information

Hospital Padre Americo (Portugal)
Hospital/treatment centre

c/o Dr E Lafuente
Intensive Care Unit
Guilhufe
Penafiel
4560-007
Portugal

ROR logo "ROR" https://ror.org/003zfh275

Funders

Funder type

Other

Investigator initiated and funded (UK) - provided by UK honoraria

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/07/2010 Yes No